Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT06480123
PHASE1/PHASE2

Stem Cell Derived Exome for Treatment of Diabetic Foot

Sponsor: Second Affiliated Hospital of Guangzhou Medical University

View on ClinicalTrials.gov

Summary

This trial is designed to investigate the safety and efficacy of patients with diabetic foot by using stem cell derived exome.

Official title: Skin Drug Prepared From Stem Cell Derived Exome for Treatment of Diabetic Foot: a Phase II Clinical Trial

Key Details

Gender

All

Age Range

18 Years - 90 Years

Study Type

INTERVENTIONAL

Enrollment

50

Start Date

2024-08-01

Completion Date

2033-12-30

Last Updated

2024-06-28

Healthy Volunteers

No

Interventions

DRUG

Skin drug prepared with exome originated from stem cell

Skin drug prepared with exome originated from stem cell will be applied to patient with diabetic foot.

Locations (1)

The Second Affiliated Hospital of Guangzhou Medical University

Guangzhou, Guangdong, China